High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium

Journal of Cellular Physiology

Volumn 215, Issue 3, 2008, Pages 645-656

  Puebla, Carlos ^a   Farías, Marcelo ^a   González, Marcelo ^a   Vecchiola, Andrea ^a   Aguayo, Claudio ^a,d   Krause, Bernardo ^a,b   Pastor Anglada, Marçal ^c   Casanello, Paola ^a   Sobrevia, Luis ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL BÍO BÍO   (Chile)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4ALPHA PHORBOL DIDECANOATE; ADENOSINE; CALPHOSTIN C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TRANSCRIPTION FACTOR SP1; DNA; SLC29A1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SLC29A1 GENE; VASCULAR ENDOTHELIUM; 5' UNTRANSLATED REGION; CELL CULTURE; DOMINANT GENE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; THERMODYNAMICS; TRANSPORT AT THE CELLULAR LEVEL; UMBILICAL VEIN;

5' UNTRANSLATED REGIONS; ADENOSINE; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DNA; ENDOTHELIUM, VASCULAR; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GENE EXPRESSION REGULATION; GENES, DOMINANT; GLUCOSE; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; THERMODYNAMICS; TRANSCRIPTION, GENETIC; UMBILICAL VEINS;

EID: 42949099888     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21347     Document Type: Article

References (50)

1. Aguayo C, Casado J, Gonzalez M, Pearson JD, San Martín R, Casanello P, Pastor-Anglada M, Sobrevia L. 2005. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia. Placenta 26:641-653.
2. Al-Sarraj A, Day RM, Thiel G. 2005. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1. J Cell Biochem 94:153-167.
3. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. 2004. The equilibrative nucleoside transporter family, S LC29. Pflügers Arch 447:735-743.
4. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. 2002. Inhibition of protein kinase C β prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90:107-111.
5. Bogdan C. 2001. Nitric oxide and the regulation of gene expression. Trends Cell Biol 11: 66-75.
6. Burnstock G. 2006. Vessel tone and remodeling. Nat Med 12:16-17.
7. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
8. Casanello P, Torres A, Sanhueza F, González M, Farías M, Gallardo V, Pastor-Anglada M, San Martín R, Sobrevia L. 2005. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res 97:16-24.
9. Casanello P, Escudero C, Sobrevia L. 2007. Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: Implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol 5:1-16.
10. Chaudary N, Naydenova Z, Shuralyova I, Coe IR. 2004. Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovasc Res 61:780-788.
11. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bond A, Messing RO. 2004. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7:855-861.
12. Chu S, Ferro TJ. 2005. Sp1: Regulation of gene expression by phosphorylation. Gene 348:1-11.
13. Crews CM, Eriksson RL. 1992. Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: Relationship to the fission yeast byr1 gene product. Proc Natl Acad Sci USA 89:8205-8209.
14. Devés R, Boyd CA. 1998. Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol Rev 78:487-545.
15. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
16. Farias M, San Martín R, Puebia C, Pearson J, Casado J, Pastor-Anglada M, Casanello P, Sobrevia L. 2006. Nitric oxide reduces adenosine transport ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol 208:451-460.
17. Farré X, Guillen-Gómez E, Sánchez L, Hardisson D, Plaza Y, Lloberas J, Casado FJ, Palacios J, Pastor-Anglada M. 2004. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors. Int J Cancer 112:959-966.
18. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. 2003. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652-2660.
19. Fleming I, Busse R. 2003. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 284:R1-R12.
20. Garcia-Carrapato MR. 2003. The offspring of gestational diabetes. J Perinat Med 31:5-11.
21. Garfinkel S, Brown S, Wessendorf JH, Maciag T. 1994. Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells. Proc Natl Acad Sci USA 91:1559-1563.
22. González M, Flores C, Pearson JD, Casanello P, Sobrevia L. 2004. Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Eur J Physiol-Pflügers Arch 448:383-394.
23. Horovitz-Fried M, Sampson SR. 2007. Involvement of PKCalpha in insulin-induced PKCdelta expression: Importance of SP-1 and NFkappaB transcription factors. Biochem Biophys Res Commun 352:78-83.
24. Jeong SM, Lee KY, Shin D, Chung H, Jeon SH, Seong RH. 2004. Nitric oxide inhibits glucocorticoid-induced apoptosis of thymocytes by repressing the SRG3 expression. J Biol Chem 279:34373-34379.
25. Kobayashi E, Ando K, Nakano H, Iida T, Ohno H, Morimoto M, Tamaoki T. 1989. Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C.I. Fermentation, isolation, physico-chemical properties and biological activities. J Antibiot 42:1470-1474.
26. Lampl M, Jeanty P. 2004. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. Am J Hum Biol 16:237-263.
27. Leung GP, Tse CM, Man RY. 2007, Characterization of adenosine transport in H9c2 cardiomyoblasts. Int J Cardiol 116:186-193.
28. Lott ME, Hogeman C, Herr M, Gabbay R, Sinoway LI. 2007. Effects of an oral glucose tolerance test on the myogenic response in healthy individuals. Am J Physiol 292:H304-H310.
29. Montecinos VP, Aguayo C, Flores C, Wyatt AW, Pearson J, Mann G, Sobrevia L. 2000. Regulation of adenosine transport by D-glucose in human fetal endothelial cells: Involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase. J Physiol 529:777-790.
30. Muñoz G, San Martín R, Farías M, Cea L, Casanello P, Sobrevia L. 2006. Insulin restores glucose-inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium. J Cell Physiol 209:826-835.
31. Murao K, Wada Y, Nakamura T, Taylor AH, Mooradian AD, Wong NC. 1998. Effects of glucose and insulin on rat apolipoprotein A-1 gene expression. J Biol Chem 273:18959-18965.
32. Ogonowski AA, Kaesemeyer WH, Jin L, Ganapathy V, Leibach FH, Caldwell RW. 2000. Effects of NO donors and synthase agonists on endothelial cell uptake of L-arg and superoxide production. Am J Physiol 278:C136-C143.
33. Oomen PHN, Kant GD, Dullaart RPF, Reitsma WD, Smit AJ. 2002. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction. Microvasc Res 63:1-9.
34. Paradkar PN, Roth JA. 2006. Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-kappaB. J Neurochem 96:1768-1777.
35. Park SW, Wei LN. 2003. Regulation of c-myc gene by nitric oxide via inactivating NF-κB complex in P19 mouse embryonal carcinoma cells. J Biol Chem 278:29776-29782.
36. Park SK, Lin HL, Murphy S. 1997. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J 332:609-613.
37. Parks CL, Shenk T. 1996. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 271:4417-4430.
38. Puebla C, Farías M, Vecchiola A, Casanello P, Sobrevia L. 2007. Transcriptional repression of equilibrative nucleoside transporter 1 by D-glucose involves nitric oxide and Sp1 inhuman foetal endothelium. Placenta 28:A.24. (Abstract).
39. Sakowicz M, Szutowicz A, Pawelczyk T. 2005. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes. Int Immunol 17:145-154.
40. San Martín R, Sobrevia L. 2006. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27:1-10.
41. Sellak H, Yang X, Cao X, Cornwell T, Soff GA, Lincoln T. 2002. Sp1 transcription factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-1α expression in vascular smooth muscle cells. Circ Res 90:405-412.
42. Soler C, Felipe A, Casado FJ, Celada A, Pastor-Anglada M. 2000. Nitric oxide regulates nucleoside transport in activated B lymphocytes. J Leukoc Biol 67:345-349.
43. Starzynski RR, Goncalves AS, Muzeau F, Tyrolczyk Z, Smuda E, Drapier JC, Beaumont C, Lipinski P. 2006. STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Biochem J 400:367-375.
44. Strohm C, Barancik M, von Bruehl M, Strniskova M, Ullmann C, Zimmermann R, Schaper W. 2002. Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning. Cardiovasc Res 55:602-618.
45. Tanaka T, Kurabayashi M, Aihara Y, Ohyama Y, Nagai R. 2000. Inducible expression of manganese superoxide dismutase by phorbol 12-myristate 13-acetate is mediated by Sp1 in endothelial cells. Arterioscler Thromb Vasc Biol 20:392-401.
46. Vásquez G, Sanhueza F, Vásquez R, González M, San Martín R, Casanello P, Sobrevia L. 2004. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 560:111-122.
47. Vásquez R, Farías M, Vega JL, San Martín R, Vecchiola A, Casanello P, Sobrevia L. 2007. D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol 212:626-632.
48. Wang S, Wang W, Wesley RA, Danner RL. 1999. A Sp1 binding site of the tumor necrosis factor α promoter functions as a nitric oxide response element. J Biol Chem 274:33190-33193.
49. Wang J, Morita I, Onodera M, Murota SI. 2002. Induction of KDR expression in bovine arterial endothelial cells by thrombin: Involvement of nitric oxide. J Cell Physiol 190:238-250.
50. Yoneyama Y, Sawa R, Suzuki S, Ishino H, Miura A, Kuwabara Y, Kuwajima T, Ito N, Kiyokawa Y, Otsubo Y, Araki T. 2002. Regulation of plasma adenosine levels in normal pregnancy. Gynecol Obstet Invest 53:71-74.